Abiopharma

🔍 Klapstein Julie D (Director)

Company: Claritev Corp (CTEV)

Report Date: 2026-04-29

Detailed Transactions and Holdings:

• Acquired 8,977 shares of Class A common stock (Direct)
  Date: 2026-04-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 24,611.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents restricted stock units which vest on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the issuer, subject to continued service through the vesting date; provided, however, that the restricted stock units vest pro rata based on the number of days of service provided to the issuer in the event of a voluntary resignation other than when grounds for termination for cause exist.